Upcoming Webinars

Improving Efficiency in Upstream Process Development

Presented by Jackie Gonzalez, Senior Upstream Development Engineer at Takeda, Klaus Mauch, CEO at Insilico Biotechnology AG
01st March 2021


A Data Driven Biopharmaceutical Manufacturing Facility-Plug and Produce -Shaping the Future Together

Presented by Josef Trapl Global Manufacturing & Supply, Head of MSci Innovation at Takeda and Petter Moree, Global Industry Principal at OSIsoft
04th March 2021


Demonstrate how machine learning tools can aid development of formulation, analysis and manufacturing of pharmaceutical drug products

Presented by Erik Skibsted, Principal Scientist PhD, Novo Nordisk Denmark and Rolf Taaning, Development Specialist PhD, Novo Nordisk Denmark
08th March 2021


Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted

Presented by Christos Varsakelis PhD, Team Lead Artificial Intelligence/Machine Learning Compound Profiling at The Janssen Pharmaceutical Companies of Johnson & Johnson, Mark Demesmaeker, Head of Data Analytics at Sartorius Stedim Biotech and Roger-Marc Nicoud, President & CEO Ypso-Facto
10th March 2021


Development and Implementation of Intensified Bioprocessing for Biologics Manufacturing

Presented by Hang Zhou, Ph.D., Vice President, Head of Cell Culture Process Development Biologics and Bioprocess Dept. at WuXi Biologics
12th March 2021


Hybrid Models: The Best of Both (Mechanistic & Empirical) Worlds to Accelerate and De-Risk Process Development

Presented by Christian Airiau, PhD, Global Head Data Sciences, Biologics Development at Sanofi and Chris McCready, Lead Data Scientist at Sartorius Stedim Biotech
16th March 2021


ICH Q3E Guidelines and Its Implications

Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Dries Cardoen, Team Leader of Study Directors Inhalation/topical/transdermal products at Nelson Laboratories, LLC
22nd March 2021


Microbiological Attributes, Specifications and Risk Assessment of Culture-based Therapeutic Products

Presented by Tony Cundell, PHD. Principal Consultant, Microbiological Consulting, LLC,
24th March 2021


Mechanistic Modelling in Early Stage Chromatography Process Development for Improving Process Efficiency and Productivity

Presented by Yuyi Shen, Associate Director, Process Development and Manufacturing at Bolt Therapeutics
19th April 2021


The Common Road to Quality for Single Use Materials

Presented by Trishna Ray-Chaudhuri, PhD, Principal Technical Manager, Genentech- A Member of the Roche Group and Kevin Mullen, Sr. Product Manager, Single-Use Systems at Thermo Fisher Scientific
21st April 2021


Risk Assessment of Extractables and Leachables in Different Phases of Development.

Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals
22nd April 2021


Mycoplasma Testing: Past, Current, and Future State

Presented by Kenneth Tai, Senior Manager, Analytical Science and Technology at Kite Pharma, Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
29th April 2021


Exosome Manufacture Based on the iCELLis® Bioreactor Platform

Presented by David Haylock, CEO VivaZome Therapuetics and Roberto Ciboldi, Senior Scientist, Purification Team, Scientific & Laboratories Services Pall Corporation
11th May 2021


Latest Analytical Techniques in Extractable and Leachables

Presented by Dr. Tom van Wijk, Abbott Healthcare Products BV, Weesp, Principal Scientist, Analytical Science and Technology Team lead Pharmaceutical analysis
20th May 2021